tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

CANF Stock Latest News

Can-Fite BioPharma Gains FDA Compassionate Use Approval for Namodenoson
Company AnnouncementsCan-Fite BioPharma Gains FDA Compassionate Use Approval for Namodenoson
20m ago
6K
CANF
Can-Fite BioPharma says medical centers seek authorization for namodenoson
PremiumThe Fly
Can-Fite BioPharma says medical centers seek authorization for namodenoson
1h ago
CANF
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
22h ago
PTN
ARTL
Can-Fite BioPharma Announces $3 Million Direct Offering
PremiumCompany Announcements
Can-Fite BioPharma Announces $3 Million Direct Offering
2d ago
6K
CANF
Can-Fite price target lowered to $4.50 from $12 at Alliance Global Partners
PremiumThe Fly
Can-Fite price target lowered to $4.50 from $12 at Alliance Global Partners
2d ago
CANF
Can-Fite BioPharma Reports 2024 Financial Results and Clinical Progress
PremiumCompany AnnouncementsCan-Fite BioPharma Reports 2024 Financial Results and Clinical Progress
2d ago
CANF
Can-Fite BioPharma Secures $3 Million in Direct Offering
Premium
Company Announcements
Can-Fite BioPharma Secures $3 Million in Direct Offering
3d ago
6K
CANF
Can-Fite BioPharma trading resumes
Premium
The Fly
Can-Fite BioPharma trading resumes
3d ago
CANF
Can-Fite BioPharma announces $3.0M registered direct offering of ADSs
PremiumThe Fly
Can-Fite BioPharma announces $3.0M registered direct offering of ADSs
3d ago
CANF
Can-Fite BioPharma trading halted, news pending
PremiumThe Fly
Can-Fite BioPharma trading halted, news pending
3d ago
CANF
Can-Fite Projects $685M Revenue from Partnerships
PremiumCompany Announcements
Can-Fite Projects $685M Revenue from Partnerships
3d ago
6K
CANF
Can-Fite BioPharma announces completion of analysis of current partnerships
PremiumThe Fly
Can-Fite BioPharma announces completion of analysis of current partnerships
3d ago
CANF
Can-Fite BioPharma Reports 2024 Financial Results and Clinical Advances
PremiumCompany AnnouncementsCan-Fite BioPharma Reports 2024 Financial Results and Clinical Advances
3d ago
6K
CANF
Can-Fite BioPharma reports FY24 EPS 0c vs 1c last year
Premium
The Fly
Can-Fite BioPharma reports FY24 EPS 0c vs 1c last year
3d ago
CANF
Can-Fite BioPharma initiates Phase 3 psoriasis study of piclidenoson
Premium
The Fly
Can-Fite BioPharma initiates Phase 3 psoriasis study of piclidenoson
23d ago
CANF
CANF Earnings this Week: How Will it Perform?
PremiumPre-Earnings
CANF Earnings this Week: How Will it Perform?
23d ago
CANF
Can-Fite BioPharma Advances Canine Osteoarthritis Treatment with Vetbiolix Partnership
PremiumCompany Announcements
Can-Fite BioPharma Advances Canine Osteoarthritis Treatment with Vetbiolix Partnership
28d ago
6K
CANF
Can-Fite BioPharma to Begin Phase II Study for Lowe Syndrome Treatment
PremiumCompany Announcements
Can-Fite BioPharma to Begin Phase II Study for Lowe Syndrome Treatment
29d ago
6K
CANF
Can-Fite BioPharma to initiate Phase II study in Lowe Syndrome
PremiumThe Fly
Can-Fite BioPharma to initiate Phase II study in Lowe Syndrome
29d ago
CANF
FDA Approves Compassionate Use of Can-Fite’s Namodenoson for Pancreatic Cancer
PremiumCompany AnnouncementsFDA Approves Compassionate Use of Can-Fite’s Namodenoson for Pancreatic Cancer
1M ago
6K
CANF
Can-Fite announces FDA approved compassionate use treatment of Namodenoson
Premium
The Fly
Can-Fite announces FDA approved compassionate use treatment of Namodenoson
1M ago
CANF
Can-Fite BioPharma’s Namodenoson Shows Promise in Liver Cancer Treatment
Premium
Company Announcements
Can-Fite BioPharma’s Namodenoson Shows Promise in Liver Cancer Treatment
2M ago
6K
CANF

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >